TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2017 DA - 2017// TI - Cancer statistics, 2017 JO - CA Cancer J Clin VL - 67 UR - https://doi.org/10.3322/caac.21387 DO - 10.3322/caac.21387 ID - Siegel2017 ER - TY - JOUR AU - Stein, J. P. PY - 2001 DA - 2001// TI - Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 19 UR - https://doi.org/10.1200/JCO.2001.19.3.666 DO - 10.1200/JCO.2001.19.3.666 ID - Stein2001 ER - TY - JOUR AU - Maase, H. PY - 2005 DA - 2005// TI - Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.07.757 DO - 10.1200/JCO.2005.07.757 ID - Maase2005 ER - TY - JOUR AU - Sternberg, C. N. AU - Vogelzang, N. J. PY - 2003 DA - 2003// TI - Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancers JO - Crit Rev Oncol Hematol VL - 46 UR - https://doi.org/10.1016/S1040-8428(03)00068-4 DO - 10.1016/S1040-8428(03)00068-4 ID - Sternberg2003 ER - TY - JOUR AU - Dong, F. PY - 2017 DA - 2017// TI - Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study JO - Cancer Manag Res VL - 9 UR - https://doi.org/10.2147/CMAR.S148856 DO - 10.2147/CMAR.S148856 ID - Dong2017 ER - TY - JOUR AU - Tsao, M. N. PY - 2012 DA - 2012// TI - Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline JO - Pract Radiat Oncol VL - 2 UR - https://doi.org/10.1016/j.prro.2011.12.004 DO - 10.1016/j.prro.2011.12.004 ID - Tsao2012 ER - TY - JOUR AU - Rades, D. PY - 2008 DA - 2008// TI - Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT + SRS) for one to three brain metastases JO - Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al VL - 184 UR - https://doi.org/10.1007/s00066-008-1946-8 DO - 10.1007/s00066-008-1946-8 ID - Rades2008 ER - TY - JOUR AU - Brown, P. D. PY - 2016 DA - 2016// TI - Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial JO - JAMA VL - 316 UR - https://doi.org/10.1001/jama.2016.9839 DO - 10.1001/jama.2016.9839 ID - Brown2016 ER - TY - JOUR AU - Mahmoud-Ahmed, A. S. PY - 2002 DA - 2002// TI - Brain metastases from bladder carcinoma: presentation, treatment and survival JO - J Urol VL - 167 UR - https://doi.org/10.1016/S0022-5347(05)64996-8 DO - 10.1016/S0022-5347(05)64996-8 ID - Mahmoud-Ahmed2002 ER - TY - JOUR AU - Fokas, E. AU - Henzel, M. AU - Engenhart-Cabillic, R. PY - 2010 DA - 2010// TI - A comparison of radiotherapy with radiotherapy plus surgery for brain metastases from urinary bladder cancer: analysis of 62 patients JO - Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al VL - 186 UR - https://doi.org/10.1007/s00066-010-2159-5 DO - 10.1007/s00066-010-2159-5 ID - Fokas2010 ER - TY - JOUR AU - Bellmunt, J. PY - 2010 DA - 2010// TI - Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.25.4599 DO - 10.1200/JCO.2009.25.4599 ID - Bellmunt2010 ER - TY - JOUR AU - Ishioka, J. PY - 2012 DA - 2012// TI - Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis JO - Br J Cancer VL - 107 UR - https://doi.org/10.1038/bjc.2012.254 DO - 10.1038/bjc.2012.254 ID - Ishioka2012 ER - TY - JOUR AU - Balachandran, V. P. AU - Gonen, M. AU - Smith, J. J. AU - DeMatteo, R. P. PY - 2015 DA - 2015// TI - Nomograms in oncology: more than meets the eye JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(14)71116-7 DO - 10.1016/S1470-2045(14)71116-7 ID - Balachandran2015 ER - TY - JOUR AU - Tibshirani, R. PY - 1996 DA - 1996// TI - Regression shrinkage and selection via the Lasso JO - J R Stat Soc Ser B Methodol VL - 58 ID - Tibshirani1996 ER - TY - JOUR AU - Mayr, R. PY - 2012 DA - 2012// TI - Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder JO - BJU Int VL - 110 UR - https://doi.org/10.1111/j.1464-410X.2012.10938.x DO - 10.1111/j.1464-410X.2012.10938.x ID - Mayr2012 ER - TY - JOUR AU - Herr, H. W. AU - Donat, S. M. AU - Bajorin, D. F. PY - 2001 DA - 2001// TI - Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer JO - J Urol VL - 165 UR - https://doi.org/10.1016/S0022-5347(05)66533-0 DO - 10.1016/S0022-5347(05)66533-0 ID - Herr2001 ER - TY - JOUR AU - Chen, C. AU - Hu, L. AU - Chen, Y. AU - Hou, J. PY - 2017 DA - 2017// TI - The prognostic value of histological subtype in patients with metastatic bladder cancer JO - Oncotarget VL - 8 ID - Chen2017 ER - TY - JOUR AU - Nakagawa, T. PY - 2017 DA - 2017// TI - Oncologic outcome of metastasectomy for urothelial carcinoma: who is the best candidate? JO - Ann Surg Oncol VL - 24 UR - https://doi.org/10.1245/s10434-017-5970-8 DO - 10.1245/s10434-017-5970-8 ID - Nakagawa2017 ER - TY - JOUR AU - Alfred Witjes, J. PY - 2017 DA - 2017// TI - Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer JO - Eur Urol VL - 71 UR - https://doi.org/10.1016/j.eururo.2016.06.020 DO - 10.1016/j.eururo.2016.06.020 ID - Alfred Witjes2017 ER - TY - JOUR AU - Hussain, S. A. PY - 2012 DA - 2012// TI - A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer JO - Oncol Lett VL - 3 ID - Hussain2012 ER - TY - JOUR AU - Morales-Barrera, R. PY - 2012 DA - 2012// TI - Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function JO - Eur J Cancer Oxf Engl VL - 1990 UR - https://doi.org/10.1016/j.ejca.2012.04.002 DO - 10.1016/j.ejca.2012.04.002 ID - Morales-Barrera2012 ER - TY - JOUR AU - Ghahestani, S. M. AU - Shakhssalim, N. PY - 2009 DA - 2009// TI - Palliative treatment of intractable hematuria in context of advanced bladder cancer: a systematic review JO - Urol J VL - 6 ID - Ghahestani2009 ER - TY - JOUR AU - Tsao, M. N. PY - 2012 DA - 2012// TI - International practice survey on the management of brain metastases: third international consensus workshop on palliative radiotherapy and symptom control JO - Clin Oncol VL - 24 UR - https://doi.org/10.1016/j.clon.2012.03.008 DO - 10.1016/j.clon.2012.03.008 ID - Tsao2012 ER -